​

Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?

OverviewForecastFinancialsChartTranscripts

Anavex Life Sciences Ownership Summary

Anavex Life Sciences is owned by 43.54% institutional investors, 3.12% insiders, and 53.35% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.55% of AVXL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.19% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAnavex Life Sciences43.54%3.12%53.35%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de7.61M8.55%$23.36M
Blackrock6.39M7.75%$26.97M
Vanguard group5.03M5.90%$17.90M
State street4.51M5.07%$13.85M
Two sigma investments, lp3.25M3.65%$9.97M
Geode capital management2.19M2.46%$6.72M
Susquehanna group, llp995.66K1.12%$3.06M
Summit financial940.46K1.06%$2.89M
Goldman sachs group804.43K0.90%$2.47M
Two sigma advisers, lp758.50K0.89%$6.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sheets smith investment management135.95K0.78%$1.21M
Pvg asset management327.34K0.49%$847.82K
Allsquare wealth management52.38K0.27%$482.97K
Watts gwilliam26.00K0.07%$349.96K
Hayek kallen investment management47.11K0.05%$145.00K
Quadrant capital group141.000.04%$48.97M
Summit financial940.46K0.04%$2.89M
Abel hall56.83K0.03%$147.19K
Hikari power85.58K0.02%$263.00K
Yukon wealth management12.04K0.02%$36.98K

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp3.25M0.01%1.59M
Hrt financial lp657.88K0.01%657.88K
Vanguard fiduciary trust647.17K0.00%647.17K
Aqr capital management756.79K0.00%606.98K
Susquehanna group, llp995.66K0.00%556.16K

Top Sellers

HolderShares% AssetsChange
Wealthgarden f.s.---910.48K
Nwam---870.80K
Jupiter asset management---804.64K
Pier capital---415.91K
Essential planning, llc.---413.09K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp657.88K0.01%657.88K$2.02M
Vanguard fiduciary trust647.17K0.00%647.17K$1.99M
Sheets smith investment management135.95K0.78%135.95K$1.21M
Ieq capital69.10K0.00%69.10K$212.14K
Quadrature capital60.34K0.00%60.34K$185.23K

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Nelson, van denburg & campbell wealth management group-14.00
Stephens consulting-40.00
Pinnacle wealth planning services-43.00
Bay harbor wealth management-70.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026192-2.54%38,759,8962.56%432.42%10917.20%46-13.21%
Dec 31, 202563-68.34%8,715,170-73.43%100.69%29-67.42%21-56.25%
Sep 30, 202582-56.61%9,007,990-72.28%100.73%29-68.48%23-34.29%
Jun 30, 2025184-6.60%32,327,9853.05%372.78%89-11.00%35-23.91%
Mar 31, 20253-98.38%406,643-98.62%-0.04%2-98.04%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.96M3.19%-18.39K
Vanguard Total Stock Mkt Idx Inv2.93M3.16%-
Vanguard Morn Total Stk Mkt Idx Investor2.93M3.16%-
Vanguard US Total Market Shares ETF2.53M2.98%-
iShares Russell 2000 ETF2.43M2.62%26.28K
SPDR® S&P Biotech ETF1.12M1.31%2.50K
Vanguard Institutional Extnd Mkt Idx Tr1.04M1.12%-
Fidelity Small Cap Index883.05K0.95%14.96K
Invesco Biotechnology & Genome ETF764.01K0.89%-2.40K
iShares Russell 2000 Value ETF726.22K0.78%-1.12K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 14, 2024Donhauser Peter D.O.-Buy$10.32K
May 15, 2024Thomas Steffen-Buy$22.60K
Mar 28, 2024MISSLING CHRISTOPHER U President and CEOSell$374.97K
Jun 28, 2023MISSLING CHRISTOPHER U President and CEOSell$2.14M
May 25, 2022Skarpelos Athanasios Sell$453.00K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

AVXL Ownership FAQ

Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 43.54%, followed by 3.12% insiders and 53.34% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 35.43%, which Anavex Life Sciences exceeds.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (7.61M shares, 8.55%), Blackrock (6.39M shares, 7.75%), and Vanguard group (5.03M shares, 5.90%). Together, they hold 22.19% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

Sheets smith investment management is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 0.78% of its assets in 135.95K Anavex Life Sciences shares, valued at 1.21M$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Anavex Life Sciences shares, with 3.19% of its total shares outstanding invested in 2.96M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools